SCHEMBL3825525

SCHEMBL3825525

COC(=O)C(c1ccccc1)C1CCCN1C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 4/20 0.56
SLC6A2 P23975 1/20 0.53
SLC6A4 P31645 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22263128 0.96 SLC6A3 (0.59) SLC6A3
SCHEMBL14660800 0.96 SLC6A3 (0.59) SLC6A3
SCHEMBL22263129 0.96 SLC6A3 (0.59) SLC6A3
SCHEMBL22263131 0.96 SLC6A3 (0.59) SLC6A3
SCHEMBL14671626 0.86
SCHEMBL5665179 0.85
SCHEMBL3889978 0.85 SLC6A3 (0.47) SLC6A3
SCHEMBL14671686 0.83
SCHEMBL15980940 0.82
SCHEMBL21009685 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776355-A4 POTASSIUM CHANNEL INHIBITORS MERCK & CO INC (US) 2009-08-12 EP disclosed
EP-1776355-A2 POTASSIUM CHANNEL INHIBITORS Merck & Co., Inc. (US) 2007-04-25 EP disclosed
WO-2006028590-A1 1,1,2,2-TETRA (HETERO) ARYLETHANES OR 1,1,2-TRI (HETERO) ARYL-2-HETEROCYCLYLETHANES AS POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-03-16 WO disclosed
WO-2006014877-A2 POTASSIUM CHANNEL INHIBITORS MERCK & CO., INC. (US) 2006-02-09 WO disclosed